Treatment Approaches to Tardive Dyskinesia (16:20)

Listen in as Dr. Dawn Vanderhoef and Dr. Kaylee Mehlman, share their insights on therapeutic approaches to tardive dyskinesia, exploring its pathophysiology, its impact on the lives of patients, and management strategies for clinicians.

This podcast, “Treatment Approaches to Tardive Dyskinesia” is an educational program sponsored and co-developed by Neurocrine Biosciences and is not certified for continuing medical education. Dr. Dawn Vanderhoef is presenting on behalf of and is an employee for Neurocrine Biosciences. Dr. Kaylee Mehlman is presenting on behalf of and are paid consultants for Neurocrine Biosciences. The information presented is consistent with FDA guidelines.